Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Marcos  Langtry

Marcos Langtry

Outsourced Manufacturing and Development Director, TiGenix

Marcos Langtry is Director for Outsourced Manufacturing and Development at TiGenix. He is responsible for all external operational activities, encompassing process development and industrialization alongside clinical and commercial manufacturing. Before joining TiGenix, Marcos Langtry has held several senior level positions within Sanofi and Astra Zeneca within the areas of process development, technical operations, industrial strategy and external manufacturing; where he has acquired extensive experience with aseptically filled products and Biologic products.


Marcos Langtry holds a Master´s degree in Biochemical Engineering from University College London (UK) and an MBA from Imperial College London (UK), and he is qualified as Chartered Engineer (CEng) and Chartered Scientist (CSci).

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd